A TLR4/NF‐κB/IRF4 signaling pathway is indispensable for M. elsdenii‐mediated DC activation and thereby leads to the augment of colonic Th1 and Th17 inflammation, resulting in an exacerbation of colitis‐associated tumorigenesis. The gene discussed is NFKB1; the disease is colitis.